Bromfenac Sodium b

CAS No. 91714-93-1

Bromfenac Sodium b ( AHR 10282R;Bronuck;AHR 10282B )

Catalog No. M19449 CAS No. 91714-93-1

Bromfenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID) which has anti-inflammatory activity and may block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 42 Get Quote
50MG 87 Get Quote
100MG 110 Get Quote
200MG 165 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Bromfenac Sodium b
  • Note
    Research use only not for human use.
  • Brief Description
    Bromfenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID) which has anti-inflammatory activity and may block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2.
  • Description
    Bromfenac Sodium is a nonsteroidal anti-inflammatory drug (NSAID) which has anti-inflammatory activity and may block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2.
  • Synonyms
    AHR 10282R;Bronuck;AHR 10282B
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX1 COX-2
  • Research Area
    Endocrinology
  • Indication
    Ocular inflammation; Ocular pain

Chemical Information

  • CAS Number
    91714-93-1
  • Formula Weight
    356.15
  • Molecular Formula
    C15H11BrNO3·Na
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:66 mg/mL (185.3 mM);Ethanol:2 mg/mL (5.61 mM);Water:65 mg/mL (182.5 mM)
  • SMILES
    [Na+].NC1=C(C=CC=C1CC([O-])=O)C(=O)C1=CC=C(Br)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sancilio LF et al. Arzneimittelforschung 1987 37(5) 513-519.
molnova catalog
related products
  • Sulfinpyrazone

    A uricosuric drug that is used to reduce the serum urate levels in gout therapy.

  • Flunixin meglumin

    Flunixin Meglumin is a potent inhibitor of the enzyme cyclooxygenase used as analgesic agent with anti-inflammatory and antipyretic activity.

  • Continentalic acid

    Continentalic acid from Aralia continentalis has minimum inhibitory concentrations (MICs) of approximately 8-16 μg/mL against S. aureus.